Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anaptysbio (ANAB) Return on Invested Capital (2018 - 2025)

Anaptysbio filings provide 6 years of Return on Invested Capital readings, the most recent being 1.51% for Q3 2025.

  • For the quarter ending Q3 2025, Return on Invested Capital rose 163.0% year-over-year to 1.51%, compared with a TTM value of 1.51% through Sep 2025, up 163.0%, and an annual FY2024 reading of 0.38%, up 47.0% over the prior year.
  • Return on Invested Capital hit 1.51% in Q3 2025 for Anaptysbio, down from 0.31% in the prior quarter.
  • The five-year high for Return on Invested Capital was 0.31% in Q2 2025, with the low at 5.64% in Q2 2024.
  • Median Return on Invested Capital over the past 3 years was 1.54% (2023), compared with a mean of 1.83%.
  • The sharpest move saw Return on Invested Capital surged 119bps in 2024, then soared 595bps in 2025.
  • Year by year, Return on Invested Capital stood at 1.58% in 2023, then skyrocketed by 75bps to 0.39% in 2024, then crashed by -283bps to 1.51% in 2025.
  • According to Business Quant data, Return on Invested Capital over the past three periods came in at 1.51%, 0.31%, and 0.3% for Q3 2025, Q2 2025, and Q1 2025 respectively.